Clinical Research Directory
Browse clinical research sites, groups, and studies.
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions
Sponsor: Yale University
Summary
To establish the effectiveness and tolerability of standard of care anti-anginal treatment (beta-blocker and calcium channel blocker medications) in older adults with symptomatic Stable Ischemic Heart Disease (SIHD) and multiple chronic conditions (MCC).
Official title: A Trial Comparing the Effectiveness and Tolerability of Medications in Older Adults With Stable Angina and Multiple Chronic Conditions: LIVEBETTER
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
INTERVENTIONAL
Enrollment
741
Start Date
2023-05-10
Completion Date
2027-05-30
Last Updated
2026-04-07
Healthy Volunteers
No
Conditions
Interventions
Clinician Discretion
Clinician discretion as to which BB or CCB will be used if the participant has a heart rate and blood pressure within normal limits.
Beta blocker
Selection of the specific BB and initial starting dose will be determined by the treating clinician.
Calcium channel blocker
Selection of the specific CCB and initial starting dose will be determined by the treating clinician.
Locations (10)
Yale School of Medicine
New Haven, Connecticut, United States
Wellstar Research Institute
Marietta, Georgia, United States
Cook County Health
Chicago, Illinois, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Mt. Sinai Health System
New York, New York, United States
NYC Health and Hospitals, Harlem Hospital
New York, New York, United States
Nirvana Integrative Medicine
New York, New York, United States
Duke University, School of Medicine
Durham, North Carolina, United States
Cleveland Clinic
Cleveland, Ohio, United States
Inova Health Care Services
Fairfax, Virginia, United States